Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

104.92
+2.922.86%
Post-market: 108.323.40+3.24%19:30 EDT
Volume:25.97K
Turnover:2.73M
Market Cap:131.15M
PE:- -
High:105.65
Open:104.03
Low:103.98
Close:102.00
52wk High:110.05
52wk Low:68.05
Shares:1.25M
Float Shares:1.25M
Volume Ratio:2.80
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sandoz joins mAbxience to develop emicizumab biosimilar and expand haemophilia pipeline

TIPRANKS
·
1 hour ago

Tissue Repair Shareholders Approve Delisting and Equal Access Buyback

TIPRANKS
·
5 hours ago

Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference

TIPRANKS
·
7 hours ago

TuHURA Biosciences Expands Use of Revolving Credit Facility

TIPRANKS
·
9 hours ago

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
10 hours ago

Lennar says labor availability becoming ‘more of an issue’

TIPRANKS
·
Yesterday

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Yesterday

Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial

TIPRANKS
·
Yesterday

Bank of England holds interest rates and overhauls bond sale programme

cityam
·
Yesterday

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Yesterday

Gold catches a bid as BoE leaves interest rates unchanged

Kitco
·
Yesterday

President Trump says US interest rates should be 1% or less

TIPRANKS
·
Yesterday

Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy

TIPRANKS
·
Yesterday

White House Calls Rate Increase 'Rather Unfortunate'

Dow Jones
·
Yesterday

How do central bankers decide interest rates when inflation is so unpredictable?

cityam
·
Sep 16

Inflation inches higher ahead of interest rates decision

cityam
·
Sep 16

Bank of England under pressure to raise interest rates or risk ‘losing credibility’

cityam
·
Sep 16

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

TIPRANKS
·
Sep 16

Cambium Bio Plans New Share Placement to Bolster Capital Base

TIPRANKS
·
Sep 16

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
Sep 16